Brian Niebur - 28 Jun 2021 Form 4 Insider Report for Miromatrix Medical Inc.

Role: Chief Financial Officer
Signature: /s/ Elise B. Houser, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 28 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 29 Jun 2021, 17:59:22 UTC
Previous filing: 23 Jun 2021
Next filing: 05 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MIRO	Common Stock	Conversion of derivative security		+3,334			3,334	28 Jun 2021	Direct	F2
transaction	MIRO	Common Stock	Conversion of derivative security		+3,334	+100%		6,668	28 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MIRO	Series B Preferred Stock	Conversion of derivative security		-3,334	-100%		0	28 Jun 2021	Common Stock	3,334		Direct	F1
transaction	MIRO	Series B-2 Preferred Stock	Conversion of derivative security		-3,334	-100%		0	28 Jun 2021	Common Stock	3,334		Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each share of Series B Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.
F2	Each share of Series B-2 Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering.